MACROGENICS INC — Director's Dealing 2025

May 22, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2025-05-20

Reporting Person: Chhabra Meenu (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-20	Common Stock	M	6500	—	Acquired	11000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-20	Restricted Stock Unit	$0	M	6500	Disposed		Common Stock (6500)	Direct
2025-05-21	Restricted Stock Unit	$0	A	3750	Acquired		Common Stock (3750)	Direct
2025-05-21	Stock Option (right to buy)	$1.49	A	22000	Acquired	2035-05-21	Common Stock (22000)	Direct
2025-05-21	Stock Option (right to buy)	$1.49	A	49213	Acquired	2035-05-21	Common Stock (49213)	Direct

Footnotes

F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2: The RSUs vested on May 20, 2025, which was one day prior to the Issuer's 2025 Annual Meeting of Stockholders held on May 21, 2025.

F3: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F4: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

F5: At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.